TTY Biopharm Co Ltd (台灣東洋藥品) chairman Lin Chuan (林全) yesterday refuted rumors that the company had engaged in insider trading ahead of last month’s announcement that it had won conditional rights to market Bio-NTech SE’s COVID-19 vaccine in Taiwan.
Lawmakers on Monday said they suspected that the firm was involved in insider trading, as 2,414 TTY units were traded on the Taipei Exchange on Oct. 12, surging 6.6 times from an average daily trading volume of 365 units in September.
TTY said that it had secured authorization to market the vaccines after the market closed on the same day.
Photo: CNA
The firm’s share price spiked from NT$69.5 to NT$84.3 on Oct. 15, when a total of 30,108 units were traded, before gradually falling to NT$82.2 on Monday last week, with a total 10,725 units traded, one day before TTY said it had terminated its bid to gain Bio-NTech’s authorization to market the vaccine.
The transactions must have been done by someone with insider information, Chinese Nationalist Party (KMT) Legislator William Tseng (曾銘宗) said on Monday.
“I never conducted any insider trading as I despise the behavior. I would welcome any investigation,” Lin told a news conference in Taipei.
“However, there indeed was a chance that someone conducted the insider trading, as the trading volume on Oct. 12 was too high to be normal,” Lin said.
TTY noticed the abnormal trading activity late on Oct. 12 and ran a preliminary investigation before notifying the exchange on Oct. 15, general manager Robbin Shih (施俊良) told a media briefing.
In addition to TTY employees, some officials at the Centers for Disease Control (CDC), Bio-NTech staff and local agents of China-based Shanghai Fosun Pharmaceutical Co (上海復星醫藥) were involved in the negotiations and knew TTY’s intention to introduce the vaccines, Shih said.
“I highly doubt that it was outside people who conducted the illegal trading, but I would not know who they were. I hope that prosecutors can get to the bottom of it soon,” Lin said.
TTY’s move to abandon the bid to market the vaccine in Taiwan gained attention, as the Bio-NTech and Pfizer Inc-developed vaccine had shown 90 percent effectiveness in preventing COVID-19, prompting speculation that TTY had failed to reach an agreement due to political concerns.
Lin said that TTY stopped trying to acquire the rights as the number of vaccines the CDC intends to purchase was much less than TTY’s expectations, which made the negotiations between TTY and Bio-NTech difficult.
BUSINESS UPDATE: The iPhone assembler said operations outlook is expected to show quarter-on-quarter and year-on-year growth for the second quarter Hon Hai Precision Industry Co (鴻海精密) yesterday reported strong growth in sales last month, potentially raising expectations for iPhone sales while artificial intelligence (AI)-related business booms. The company, which assembles the majority of Apple Inc’s smartphones, reported a 19.03 percent rise in monthly sales to NT$510.9 billion (US$15.78 billion), from NT$429.22 billion in the same period last year. On a monthly basis, sales rose 14.16 percent, it said. The company in a statement said that last month’s revenue was a record-breaking April performance. Hon Hai, known also as Foxconn Technology Group (富士康科技集團), assembles most iPhones, but the company is diversifying its business to
Apple Inc has been developing a homegrown chip to run artificial intelligence (AI) tools in data centers, although it is unclear if the semiconductor would ever be deployed, the Wall Street Journal reported on Monday. The effort would build on Apple’s previous efforts to make in-house chips, which run in its iPhones, Macs and other devices, according to the Journal, which cited unidentified people familiar with the matter. The server project is code-named ACDC (Apple Chips in Data Center) within the company, aiming to utilize Apple’s expertise in chip design for the company’s server infrastructure, the newspaper said. While this initiative has been
GlobalWafers Co (環球晶圓), the world’s No. 3 silicon wafer supplier, yesterday said that revenue would rise moderately in the second half of this year, driven primarily by robust demand for advanced wafers used in high-bandwidth memory (HBM) chips, a key component of artificial intelligence (AI) technology. “The first quarter is the lowest point of this cycle. The second half will be better than the first for the whole semiconductor industry and for GlobalWafers,” chairwoman Doris Hsu (徐秀蘭) said during an online investors’ conference. “HBM would definitely be the key growth driver in the second half,” Hsu said. “That is our big hope
The consumer price index (CPI) last month eased to 1.95 percent, below the central bank’s 2 percent target, as food and entertainment cost increases decelerated, helped by stable egg prices, the Directorate-General of Budget, Accounting and Statistics (DGBAS) said yesterday. The slowdown bucked predictions by policymakers and academics that inflationary pressures would build up following double-digit electricity rate hikes on April 1. “The latest CPI data came after the cost of eating out and rent grew moderately amid mixed international raw material prices,” DGBAS official Tsao Chih-hung (曹志弘) told a news conference in Taipei. The central bank in March raised interest rates by